Andrea Saggini
- Dermatology top 1%
- Immunology top 10%
- Epidemiology top 10%
- Pathology and Forensic Medicine top 5%
- Oncology
- Co-authors
- Raoul SagginiA. CaraffaP. AntinolfiPio ContiLorenzo CerroniSergio ChimentiElena ToniatoAndrea Chiricozzi
- Topics
- Mast cells and histamine (12 papers)Cutaneous lymphoproliferative disorders research (10 papers)Asthma and respiratory diseases (9 papers)
- Journals
- SHILAP Revista de lepidopterologíaInternational Journal of Molecular SciencesThe American Journal of Surgical Pathology
- Partner nations
- ItalyUnited StatesGreece
In The Last Decade
Andrea Saggini
83 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Dermatology 400
- Immunology 383
- Epidemiology 253
- Pathology and Forensic Medicine 238
- Oncology 222
Countries citing papers authored by Andrea Saggini
This map shows the geographic impact of Andrea Saggini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Saggini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Saggini more than expected).
Fields of papers citing papers by Andrea Saggini
This network shows the impact of papers produced by Andrea Saggini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Saggini. The network helps show where Andrea Saggini may publish in the future.
Co-authorship network of co-authors of Andrea Saggini
This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Saggini. A scholar is included among the top collaborators of Andrea Saggini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Saggini. Andrea Saggini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 4 | |
| 12 | 42 | |
| 13 | 14 | |
| 14 | 1 | |
| 15 | 81 | |
| 16 | Luteolin inhibits mast cell-mediated allergic inflammation | 55 |
| 17 | 14 | |
| 18 | 10 | |
| 19 | 7 | |
| 20 | 96 |
About Andrea Saggini
Andrea Saggini is a scholar working on Dermatology, Immunology and Rheumatology, having authored 84 papers that have together received 1.4k indexed citations. Recurring topics across this work include Mast cells and histamine (12 papers), Cutaneous lymphoproliferative disorders research (10 papers) and Asthma and respiratory diseases (9 papers). The work is most often cited by research in Dermatology (400 citations), Immunology (383 citations) and Pathology and Forensic Medicine (238 citations). Andrea Saggini has collaborated with scholars based in Italy, United States and Greece. Frequent co-authors include Raoul Saggini, A. Caraffa, P. Antinolfi, Pio Conti, Lorenzo Cerroni, Sergio Chimenti, Elena Toniato, Andrea Chiricozzi, Francesca Conti and Marco Rosati. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.